These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 7016144

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A, Raffo M, Sau F, Seguro C, Pirisi R.
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind trial of labetalol.
    Kane J, Gregg I, Richards DA.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
    [Abstract] [Full Text] [Related]

  • 7. A comparative study of methyldopa and labetalol in the treatment of hypertension.
    Sanders GL, Davies DM, Gales GM, Rao JG, Rawlins MD, Routledge PA.
    Br J Clin Pharmacol; 1979 Aug; 8(Suppl 2):149S-151S. PubMed ID: 393286
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M, Ansuini R, Pupita G, Campolucci G, Pupita F.
    Int J Clin Pharmacol Res; 1984 Aug; 4(5):385-7. PubMed ID: 6519853
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH.
    Pharmatherapeutica; 1981 Aug; 3(1):46-54. PubMed ID: 7033992
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H, Pogglitsch H, Katschnig H, Korthals C.
    Wien Med Wochenschr Suppl; 1981 Aug; 69():10-3. PubMed ID: 6952657
    [Abstract] [Full Text] [Related]

  • 14. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF, LaBrooy J, Munro-Faure AD.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of hypertension by labetalol (author's transl)].
    Sternon J, Melot C, Contu E.
    Rev Med Brux; 1980 Nov; 1(9):615-21. PubMed ID: 7455430
    [No Abstract] [Full Text] [Related]

  • 16. Diazoxide vs labetalol: a cross-over comparison of short-term effects in hypertension.
    Rumboldt Z, Bagatin J, Vidovic A.
    Int J Clin Pharmacol Res; 1983 Nov; 3(1):47-54. PubMed ID: 6679507
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.